The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1390-1393

  Stief, Christian G ^a   Ückert, Stefan ^a   Becker, Armin J ^a   Truss, Michael C ^a   Jonas, Udo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Erectile dysfunction; Phosphodiesterase; Smooth muscle

Indexed keywords

MILRINONE; PAPAVERINE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; QUAZINONE; ROLIPRAM; SILDENAFIL; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PENIS DISEASE; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE;

EID: 0031920611     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63622-X     Document Type: Article

References (21)

1. Jünemann, K. P. and Aken, P.: Pharmacotherapy of erectile dysfunction. Int. J. Impotence Res., 1: 71, 1989.
2. Truss, M., Becker, A. J., Schultheiss, D. and Jonas, U.: Intracavernous pharmacotherapy. World J. Urol., 15: 71, 1997.
3. Virag, R.: Intracavernous injection of papaverine for erectile failure. Letter to the editor. Lancet, 2: 938, 1982.
4. Brindley, G. S.: Cavernosal alpha-blockade: a new technique for investigating and treating erectile dysfunction. Brit. J. Psychiatr., 143: 332, 1983.
5. Zorgniotti, A. W. and Lefleur, R. S.: Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J. Urol., 133: 39, 1985.
6. Ignarro, L. J., Bush, P. A., Buga, G. M., Woods, K. S., Fukuto, J. M. and Rajfer, J.: Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Comm., 170: 843, 1990.
7. Holmquist, F., Stief, C. G., Jonas, U. and Andersson, K. E.: Effect of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol. Scand., 143: 299, 1991.
8. Burnett, A. L., Lowenstein, C. J., Bredt, D. S., Chang, T. S. K. and Snyder, S. H.: Nitric oxide: a physiologic mediator of penile erection. Science, 257: 401, 1992.
9. Stief, C. G., Holmquist, F., Allhoff, E. P., Andersson, K. E. and Jonas, U.: Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivo. World J. Urol., 9: 237, 1991.
10. Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J. and Ignarro, L. J.: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N. Engl. J. Med., 326: 90, 1992.
11. Taher, A., Stief, C. G., Raida, M., Jonas, U. and Forssmann, W. G.: Cyclic nucleotide phosphodiesterase activity in human cavernous smooth muscle and the effect of various selective inhibitors. Int. J. Impotence Res., 4(Suppl. 2): P11, 1992.
12. Beavo, J. A., Conti, M. and Heaslip, R. J.: Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46: 399, 1994.
13. Taher, A., Meyer, M., Stief, C. G., Jonas, U. and Forssmann, W. G.: Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J. Urol., 15: 32, 1997.
14. Stief, C. G., Benard, F., Bosch, R., Aboseif, S., Lue, T. F. and Tanagho, E. T.: The rabbit as a model for neurourological studies of the lower genitourinary tract. World J. Urol., 8: 233, 1990.
15. Stief, C. G., Bähren, W., Gall, H. and Scherb, W.: Functional evaluation of penile hemodynamics. J. Urol., 139: 734, 1988.
16. Nicholson, C. D., Challiss, R. A. and Shahid, M.: Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci., 12: 19, 1991.
17. Taher, A., Schulz-Knappe, P., Meyer, M., Truss, M. C., Forssmann, W. G., Stief, C. G. and Jonas, U.: Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J. Urol., 12: 286, 1994.
18. Truss, M. C., Ückert, S., Stief, C. G., Schulz-Knappe, P., Hess, R., Forssmann, W. G. and Jonas, U.: Porcine detrusor cyclic nucleotide phosphodiesterase (PDE) isoenzymes: characterization and functional effects of various PDE inhibitors. Urology, 45: 893, 1995.
19. Ballard, S., Burslem, F. M. F., Gingell, C. J. C., Price, M. E., Tang, K., Turner, L. A. and Naylor, A. M.: In vitro profile of UK 92480, an inhibitor of cyclic GMP-specific phosphodiesterase V for the treatment of erectile dysfunction. J. Urol., 155: 676A, 1996.
20. Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Osterloh, I. H. and Gingell, C.: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. IJIR, 8: 47, 1996.
21. Sparwasser, C., Drescher, P., Will, J. and Madsen, P. O.: Smooth muscle tone regulation in the rabbit cavernosal ans spongiosal tissue by cyclic AMP and cyclic GMP-dependent mechanisms. J. Urol., 152: 2159, 1994.